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Background
Glycoproteins make up the bulk of biologically-derived
medicines, and are taking up an ever increasing share of
the prescription pharmaceuticals market. As opposed to
small molecule drugs, glycoproteins are large complex
molecules with heterogeneity arising from a multitude
of glycan moieties. Glycans are complex post-translation
modifications, which result from a number of enzymatic
reactions in the ER and Golgi collectively known as gly-
cosylation and play an important role in pharmacoki-
netics such as drug safety, efficacy and half-life. It is
known that the availability of the nucleotide sugar
donors (NSDs), which are the co-substrates to the enzy-
matic glycosylation reactions of the Golgi, can be
affected by a number of process conditions such as cul-
ture mode, temperature, dissolved oxygen and nutrient
availability, as well as the addition of precursor mole-
cules to the culture medium [1]. Consequently, feeding
strategies of nucleotide and nucleotide sugar precursors
have been explored to exert control over the glycoform
[2,3]. In this work, a mathematical model platform is
presented to quantify the impact of nutrient availability
and feeding strategies on the glycosylation process with
the aim to enable the design of feeding strategies to
optimise the product glycoform.
Model development
As part of this work the Jedrzejewski et al. modelling
platform was developed and trained further for
improved model confidence and performance [4]. The
framework links the extracellular environment, through
the availability of intracellular metabolites in the
cytoplasm and the Golgi apparatus, to the glycosylation
of the conserved glycan site of the IgG heavy chain. The
model platform comprises four parts, which are inter-
linked through dynamic fluxes and metabolite concen-
trations:
• A modified cell growth model based on Monod
kinetics capturing cell culture dynamics and the
impact of various hexose and nucleotide precursor
additions to the cell culture media;
• A semi-structured purine and pyrimidine synthesis
network describing the intracellular concentrations
of nucleotide triphosphates, which are the co-sub-
strates of NSD synthesis;
• A structured and mechanistic representation of the
NSD synthesis pathway;
• The del Val et al. model describing the N-linked
glycosylation process of the conserved glycan struc-
ture of the IgG antibody heavy chain [5].
The main focus of the work has been on the bottom-
up mechanistic in silico reconstruction of the NSD
synthesis network. The 34 species that make up the
metabolic network were represented by means of mass
balances that are connected through a network of 60
reactions, which were modelled as saturation rate
kinetics based on reaction mechanisms found in the lit-
erature. The model platform is able to reproduce cell
growth dynamics, extracellular nutrient availability,
dynamic intracellular NSD and nucleotide concentra-
tions, product titer and the antibody product glycoform.
Results
Refinement of the original Jedrzejewski et al. model fra-
mework and further training was achieved through a
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two-step CHO cell-based experimental process. All cul-
tures were grown on the CD-CHO and CD Efficient-
FeedTM C platform (Life Technologies, Paisley, U.K.).
In a first set of experiments, the experimental aim was
to elicit a dynamic response of the NSD species GDP-
Fuc and GDP-Man, to increase model confidence. The
cells were fed with 10 mM mannose and 1 mM or
0.25 mM guanosine on day 5 of cell culture. Exploration
of this part of metabolism was particularly important for
the mechanistic representation of the NSD synthesis
network, where inhibitory and control mechanisms
across the network structure play an important role. In
addition, the feeding of the nucleotide precursor guano-
sine was able to perturb and probe guanosine tripho-
sphate (GTP) synthesis. The data allowed a model
extension to fed-batch operation and including the
impact of mannose and uridine additions on cell culture
dynamics and nucleotide synthesis. A second set of
experiments aimed at probing the metabolic factors
affecting antibody galactosylation. In this experiment all
CHO cell cultures were grown in manganese chloride-
supplemented media and varying amounts of galactose
and uridine were fed on days 4 and 8 of culture. The
effects were dynamic perturbations with respect to cell
culture dynamics, nucleotide and NSD synthesis as well
as the antibody product glycoform. Most importantly,
the effect of galactose and uridine addition on intracel-
lular uridine diphosphate galactose (UDP-Gal) concen-
tration (Figure 1) and the resulting increase in antibody
product galactosylation were observed. An increase of
up to 40% in galactosylation in the terminal product gly-
coform was observed as compared to the control cul-
tures. Dynamic perturbations of intracellular uridine
triphosphate were also observed and enabled further
refinement of the nucleotide synthesis model structure.
Conclusions
We have developed a mathematical model that links the
extracellular environment to protein product glycoform
for CHO cell cultures grown under batch and fed-batch
conditions. The model output is in good agreement
with data from a variety of culture conditions and is
able to capture the dynamic impact of hexose and
nucleotide precursor additions to culture media and
their impact on NSD concentrations and product glyco-
form. Data from an experiment in which galactose and
uridine were added to the cell culture media, in particu-
lar, extended the dynamic range of the model platform
to regimes known to increase antibody galactosylation.
Following this extensive model development and
Figure 1 Intracellular UDP-Gal concentrations for all five conditions of the 2nd set of experiments with respect to culture time. Feeding
of galactose and/or uridine on days 4 and 8 of culture is indicated by the overhead arrows.
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training exercise, the platform can now be used as an in
silico tool towards designing feeding strategies to alter
and drive the galactosylation of mAbs. Lastly, the modu-
lar nature of the framework allows it to be coupled with
other models to translate the framework to other expres-
sion systems, operation modes and culture conditions.
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